Control of mammary stem cell function by steroid hormone signalling
Details
Publication Year 2010-06-10,Volume 465,Issue #7299,Page 798-802
Journal Title
NATURE
Publication Type
Journal Article
Abstract
The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk(1-3), underpinning the benefit of endocrine therapies in the treatment of breast cancer(4). Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence(5,6). Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term(7). The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs)(8,9) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors(10). Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.
Publisher
NATURE PUBLISHING GROUP
Keywords
ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER RISK; GLAND DEVELOPMENT; PROGESTERONE-RECEPTOR; EPITHELIAL-CELLS; MICE LACKING; PROLIFERATION; DIFFERENTIATION; MORPHOGENESIS; LIGAND
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2010-06-10 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙